Alice Bradbury
Professor Nicola Curtin
Dr Yvette Drew
| The Role of ATR Inhibitors in Ovarian Cancer: Investigating Predictive Biomarkers of Response | 2022 |
|
Alice Bradbury
Dr Rachel O'Donnell
Dr Yvette Drew
Professor Nicola Curtin
Dr Sweta Sharma Saha
et al. | Characterisation of ovarian cancer cell line NIH-OVCAR3 and implications of genomic, transcriptomic, proteomic and functional DNA damage response biomarkers for therapeutic targeting | 2020 |
|
Alice Bradbury
Sally Hall
Professor Nicola Curtin
Dr Yvette Drew
| Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations? | 2020 |
|
Lucy Gentles
Liz Matheson
Dr Nicholas Bown
Alice Bradbury
Maryam Zanjirband Zanjirband
et al. | Characterization and drug sensitivity of a novel human overian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor | 2018 |
|
Dr Stuart Rundle
Alice Bradbury
Dr Yvette Drew
Professor Nicola Curtin
| Targeting the ATR-CHK1 Axis in Cancer Therapy | 2017 |
|
